mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |
mRNA |
nakiterpiosin |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
2e-05 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
5e-05 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-05 |